Nanomedicines for targeted delivery of etoposide to non-small cell lung cancer using transferrin functionalized nanoparticles. Issue 61 (4th July 2015)

• Record Type: Journal Article
• Authors: Pooja, Deep; Kulhari, Hitesh; Tunki, Lakshmi; Chinde, Srinivas; Kuncha, Madhusudana; Grover, Paramjit; Rachamalla, Shyam S.; Sistla, Ramakrishna
• Is Part Of: RSC advances. Volume 5:Issue 61(2015)
• Page Start: 49122
• Page End: 49131
• Publication Date: 2015-07-04
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c5ra03316k
• Languages: English
• ISSNs: 2046-2069

Abstract

<abstract abstract-type="toc"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <graphic position="anchor" id="ga" xlink:href="ark:/27927/pgj105c9w7m" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" />Tf-conjugated solid lipid nanoparticles were designed for selectively targeting etoposide to human non-small cell lung cancer resulting in sustained drug release, improved plasma concentrations and accumulation of etoposide in targeted lung tissues.</p> </abstract>